Abstract:Background Right heart failure may lead to impaired liver perfusion and venous congestion, resulting in different extents of liver fibrosis. However, whether hepatic tissue deterioration determined by native T1 mapping and extracellular volume fraction using cardiac magnetic resonance imaging is associated with poor outcomes in patients with pulmonary arterial hypertension remains unclear. Methods and Results A total of 131 participants with pulmonary arterial hypertension (mean age, 36±13 years) and 64 healthy controls (mean age, 44±18) between October 2013 and December 2019 were prospectively enrolled. Hepatic native T1 and extracellular volume fraction values were measured using modified Look–Locker inversion recovery T1 mapping sequences. The primary end point was all‐cause mortality; the secondary end point was all‐cause mortality and repeat hospitalization attributable to heart failure. Cox regression models and Kaplan–Meier survival analysis were used to identify the association between variables and clinical outcome. During a median follow‐up of 34.5 months (interquartile range: 25.3–50.8), hepatic native T1 (hazard ratio per 30‐ms increase, 1.22 [95% CI, 1.07–1.39]; P =0.003) and extracellular volume fraction (hazard ratio per 3% increase, 1.18 [95% CI, 1.04–1.34]; P =0.010) values were associated with a higher risk of death. In the multivariate Cox model, hepatic native T1 value (hazard ratio per 30‐ms increase, 1.15 [95% CI, 1.04–1.27]; P =0.009) remained as an independent prognostic factor for the secondary end point. Conclusions Hepatic T1 mapping values were predictors of adverse cardiovascular events in participants with pulmonary arterial hypertension and could be novel imaging biomarkers for poor prognosis recognition. Nonstandard Abbreviations and Acronyms 6MWD 6‐minute walk distance ECV extracellular volume fraction PAH pulmonary arterial hypertension Clinical Perspective What Is New? Hepatic native T1 and extracellular volume fraction values were abnormally increased in patients with pulmonary arterial hypertension more than in healthy volunteers, which may be novel imaging biomarkers for detecting right‐sided heart overload and failure. Increased hepatic native T1 and extracellular volume fraction values were poor prognostic signs for all‐cause mortality, which strengthened the importance of liver function management in patients with pulmonary arterial hypertension during treatment and may add therapeutic benefit. What Are the Clinical Implications? This study shed light on the clinical significance of hepatic T1 mapping assessment in patients with pulmonary arterial hypertension, bringing extra bonus for clinical use of cardiac magnetic resonance imaging and providing a novel method for evaluation of liver involvement in patients with pulmonary arterial hypertension. Pulmonary arterial hypertension (PAH) is a progressive disease leading to right heart failure and death. Therefore, evaluation of right heart function is crucial in both the diagnosis and treatment of PAH. Right heart failure may lead to impaired liver perfusion and venous congestion, resulting in differing extents of liver fibrosis depending on the degree of right heart failure. 1 The extent of liver fibrosis is associated with right atrial pressure, right atrial dilation, and right ventricular (RV) dilation. 2 A retrospective study including 9455 patients with pulmonary hypertension showed that the cumulative incidence rates of nonalcoholic fatty liver disease were significantly higher in patients with pulmonary hypertension (7.3%) than in those without pulmonary hypertension (3.5%; log‐rank test, P <0.001). Furthermore, the former patient group was more likely to develop liver cirrhosis than was the latter group. 3 The gold standard for the diagnosis and staging of liver fibrosis is liver biopsy; however, less invasive and time‐consuming and cost‐effective diagnostic methods such as transient elastography are preferred. 4 , 5 Nevertheless, both liver biopsy and transient elastography can only provide information on liver injury. In previous studies, T1 mapping sequences of car -Abstract Truncated-

Native hepatic T1-time as a non-invasive predictor of diastolic dysfunction and a monitoring tool for disease progression and treatment response in patients with pulmonary hypertension

Tissue Doppler Imaging Study of Right Ventricular Myocardial Systolic Activation in Subjects with Pulmonary Arterial Hypertension

Prognostic Value of Hepatic Native T1 and Extracellular Volume Fraction in Patients with Pulmonary Arterial Hypertension

Hepatic T1 Mapping as a Novel Cardio-Hepatic Axis Imaging Biomarker Early after STEMI

Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients

Association of Native T1 Times with Biventricular Function and Hemodynamics in Precapillary Pulmonary Hypertension.

Association between CMR derived hepatic T1 times, tricuspid regurgitation severity, and outcomes

Right ventricular function as assessed by cardiac magnetic resonance imaging-derived strain parameters compared to high-fidelity micromanometer catheter measurements

Hepatic Tissue Alterations in ST-Elevation Myocardial Infarction: Determinants and Prognostic Implications

The association between native myocardial T1 relaxation times and left atrial phasic structure and function: the UK Biobank Imaging Enhancement study

Characterization and clinical significance of right ventricular mechanics in pulmonary hypertension evaluated with cardiovascular magnetic resonance feature tracking

SYSTOLIC BLOOD PRESSURE IS ASSOCIATED WITH ELEVATED NATIVE T1 TIME IN CARDIAC MRI SUGGESTING MYOCARDIAL FIBROSIS IN PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS

The Value of Hemodynamic Measurements or Cardiac MRI in the Follow-up of Patients With Idiopathic Pulmonary Arterial Hypertension

Prognostic Value of Left Ventricular Function and Mechanics in Pulmonary Hypertension: A Pilot Cardiovascular Magnetic Resonance Feature Tracking Study

Multidimensional CT approach to predict hemodynamics in pulmonary hypertension.

Effect of Myocardial Tissue Characterization Using Native T1 to Predict the Occurrence of Adverse Events in Patients With Chronic Kidney Disease and Severe Aortic Stenosis

Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping

CMR-based heart deformation analysis for quantification of hemodynamics and right ventricular dysfunction in patients with CTEPH

Prognostic Relevance of Tricuspid Annular Plane Systolic Excursion to Systolic Pulmonary Arterial Pressure Ratio and Its Association With Exercise Hemodynamics in Patients With Normal or Mildly Elevated Resting Pulmonary Arterial Pressure

Native T1 Mapping-Based Radiomics for Noninvasive Prediction of the Therapeutic Effect of Pulmonary Arterial Hypertension

Comprehensive remote myocardium characterisation using T1 mapping in patients with ST-segment elevation myocardial infarction